HomeDiagramsDatabaseMapsForum About
     

Go Back   SkyscraperPage Forum > Regional Sections > Asia-Pacific > Malaysia


Reply

 
Thread Tools Display Modes
     
     
  #1  
Old Posted Jun 27, 2021, 11:06 AM
nazrey's Avatar
nazrey nazrey is offline
Moderator
 
Join Date: Mar 2004
Posts: 1,869
National Covid-19 Immunisation Plan (NIP)

Follow our Covid-19 vaccination tracker
See where Malaysia in the race to herd immunity





Source: New Straits Times

Last edited by nazrey; Aug 15, 2021 at 3:30 AM.
Reply With Quote
     
     
  #2  
Old Posted Jun 27, 2021, 1:33 PM
nazrey's Avatar
nazrey nazrey is offline
Moderator
 
Join Date: Mar 2004
Posts: 1,869
Malaysia aims to inoculate 60pct of population by September: Khairy Jamaluddin
By Ayisy Yusof June 23, 2021 @ 11:49am
Quote:
KUALA LUMPUR: The government aims to inoculate about 60 per cent of the population by the end of September, said Science, Technology and Innovation Minister Khairy Jamaluddin.

Khairy, which is also the Covid-19 National Immunisation Programme (NIP) coordinating minister, said the government was putting together all resources to achieve the vaccination target.

"The government has set a target of administering 150,000 vaccines shots per day in June before increasing it to 200,000 shots a day by July.

"We have reached this target ahead of schedule with 215,000 shots on June 15," he said at the launch of the World Bank's "Malaysia Economic Monitor, Weathering the Surge" report here today.

As of June 19 this year, 4.08 million individuals covering 12.5 per cent of the population had received at least one dose of the Covid-19 vaccine, with 1.58 million already receiving the full two doses.

"The government is confident of administering 11 million doses in July, 13 million doses by the end of August, and a further 8.0 million doses by the end of September," he said.
https://www.nst.com.my/business/2021...iry-jamaluddin
Reply With Quote
     
     
  #3  
Old Posted Jun 27, 2021, 1:40 PM
nazrey's Avatar
nazrey nazrey is offline
Moderator
 
Join Date: Mar 2004
Posts: 1,869
Reply With Quote
     
     
  #4  
Old Posted Jun 28, 2021, 12:45 AM
nazrey's Avatar
nazrey nazrey is offline
Moderator
 
Join Date: Mar 2004
Posts: 1,869
Vaccination rate to hit 300,000 a day by August
By Rizalman Hammim June 8, 2021 @ 2:23pm

Quote:
ISKANDAR PUTERI: The government is confident that the vaccination rate in the country would hit 300,000 a day by August.

Minister of Science, Technology and Innovation Khairy Jamaluddin said this would depend on whether the vaccines arrived on schedule.

"That is why I am visiting the states, to ensure that the necessary facilities are in place to allow us to ramp up the vaccination rate.

"We are targeting a vaccination rate of 200,000 a day by July and 300,000 a day by August. If we can do this, I am confident we can achieve our target of vaccinating 80 per cent of the population by October," he said.
https://www.nst.com.my/news/nation/2...000-day-august
Reply With Quote
     
     
  #5  
Old Posted Jul 2, 2021, 11:46 PM
nazrey's Avatar
nazrey nazrey is offline
Moderator
 
Join Date: Mar 2004
Posts: 1,869
Malaysian mRNA vaccine against Covid-19 under development, says Adham
Bernama June 21, 2021 17:54 pm +08


Quote:
PUTRAJAYA (June 21): Malaysia is developing a vaccine to protect against Covid-19 using the messenger ribonucleic acid (mRNA) technology.

The Malaysian Institute for Medical Research (IMR) started developing it with Universiti Putra Malaysia (UPM) in November 2020, said Health Minister Datuk Seri Dr Adham Baba at a joint press conference with National Covid-19 Immunisation Programme Coordinating Minister Khairy Jamaluddin today.

“The original SARS-CoV-2 virus and its variants are now in the cloning stage,” he said about the current status of vaccine development.

He said that the process includes testing in small and big animals (in the pre-clinical stage), then three phases of clinical trials in humans, before the vaccine can be registered and mass-produced.

With regard to healthcare workers reinfected with the virus after two vaccine shots, Adham said there were 1,480 cases with a single category 4 case suffering from pneumonia and requiring respiratory support.

He said that the majority of cases were in categories 1 or 2, and suffered no symptoms or symptoms sans pneumonia.

“This shows that the vaccines protect people against serious symptoms. The data also shows its effectiveness in healthcare workers,” he said.

Adham said that genomic surveillance efforts had identified 183 Covid-19 variants, with 167 being variants of concern (VOC) and 16 variants of interest (VOI).

“Therefore, surveillance will continue for the next three months,” he said.
https://www.theedgemarkets.com/artic...er-development
Reply With Quote
     
     
  #6  
Old Posted Jul 8, 2021, 11:40 PM
nazrey's Avatar
nazrey nazrey is offline
Moderator
 
Join Date: Mar 2004
Posts: 1,869
Malaysia sets new daily vaccination record with 375,842 doses administered on July 7, cumulative shots topped 10 mil
Syafiqah Salim July 08, 2021 09:41 am +08








Quote:
KUALA LUMPUR (July 8): Malaysia achieved its highest Covid-19 vaccine doses administered so far, recording 375,842 doses administered yesterday (July 7).

Of this, 207,795 people have received their first dose while 168,047 have received both doses, according to the latest tweets by the Covid-19 Vaccine Supply Access Guarantee Special Committee (JKJAV), citing data from the Covid-19 Immunisation Task Force (CITF).

This is the third consecutive day that the country delivered more than 300,000 daily shots. A total of 313,761 vaccine doses were administered on Monday, while 340,043 doses were administered on Tuesday.
https://www.theedgemarkets.com/artic...mulative-shots
Reply With Quote
     
     
  #7  
Old Posted Jul 14, 2021, 11:17 PM
nazrey's Avatar
nazrey nazrey is offline
Moderator
 
Join Date: Mar 2004
Posts: 1,869
Quote:
Originally Posted by nazrey View Post
Malaysian mRNA vaccine against Covid-19 under development, says Adham
Bernama June 21, 2021 17:54 pm +08



https://www.theedgemarkets.com/artic...er-development
Roadmap to making our own vaccines
By Veena Babulal June 19, 2021 @ 8:10am

Quote:


The budget approved for laboratory and animal studies in IMR’s Covid-19 vaccine development amounts to RM3.1 million. -NSTP/ASYRAF HAMZAH

Malaysia has officially entered the global race to develop Covid-19 vaccines, following the recent announcement by Health Minister Datuk Seri Dr Adham Baba. Apart from looking at the timeline for the country to come up with those vaccines, the scientific community is also gearing up for improved level of preparedness in the face of other pandemics without relying on others. In this interview with the 'New Straits Times', Institute for Medical Research director Dr Tahir Aris tells the NST what is being done.

Question: What is the development stage now for both the mRNA (messenger ribonucleic acid) and inactivated virus vaccines?


Answer: We started initiatives into vaccine development from the early part of the epidemic last year. We chose to embark on two platforms, namely the mRNA and inactivated virus vaccines.

Discussions and planning have started since March last year. However, the laboratory work began only after we received research funding from the Health Ministry.

We started work on the inactivated virus vaccine in January this year, while the mRNA project began in November last year. Both the vaccines' research and development (R&D) are at exploratory or early stages only.


For the inactivated virus vaccine, we have managed to isolate, identify and propagate the potential strain. The next step is to optimise the inactivation process.

After this stage, we will proceed to use animal models. The progress of this vaccine is going according to plan.

The mRNA vaccine is still at "proof-of-concept" stage, where the specific viral gene sequences are being analysed. This stage is very important to ensure that the candidate vaccine is able to elicit the immune response against SARS-CoV-2.



Institute for Medical Research director Dr Tahir Aris.

Q: How much has the ministry allocated to develop the vaccines?

A: The budget approved for the development of the vaccines are for laboratory and animal studies only, amounting to RM3.1 million. Additional funding will be applied for pre-clinical and clinical studies.

Q: Is the initiative undertaken wholly by the Institute for Medical Research (IMR) and the Health Ministry, or is it a joint venture with others? Can you identify other parties developing these vaccines?

A: Our researchers in these projects have background experience in microbiology, immunology and vaccinology. The projects are IMR's initiative in collaboration with the Higher Education and the Agriculture and Food Industry Ministries.

The inactivated virus (vaccine) team is headed by Dr Rozainanee Mohd Zain, a consultant clinical virologist in the Virology Unit of the Infectious Diseases Research Centre at IMR.

We are collaborating with Universiti Putra Malaysia's Veterinary Medicine Faculty and the Veterinary Research Institute (VRI) in Ipoh.

At this point, the mRNA vaccine is wholly an IMR initiative. Dr Masita Arip, a consultant microbiologist and immunologist at IMR's Allergy and Immunology Research Centre, is heading the project.

Q: Who will own the intellectual property (IP) rights if the research or R&D for both vaccines succeed?

A: An MoU will be signed between the parties involved and this will include the terms and conditions on IP rights. The researchers and institutions, or universities involved, will share the rights.

Q: Can you elaborate on the timeline?

A: The laboratory studies of the inactivated vaccine, including the pre-clinical studies on animals, are to be done by the end of next year (Pre-clinical studies are expected to start in August and animal studies conducted at VRI are expected to be completed by March next year).

This includes analysis on the efficacy and safety of the potential vaccine. We hope to start phase 1 of the clinical studies by January 2023. For mRNA vaccine, we plan to start the clinical trial by 2025.



The Institute for Medical Research has isolated, identified and propagated the potential strain in developing its inactivated virus vaccine, while the mRNA vaccine is still at ‘proof-of-concept’ stage. -NSTP/ASYRAF HAMZAH

Q: Can you elaborate on the process of developing the inactivated virus vaccine? How do you address the bio-security hazards?

A: One of the project activities for the inactivated vaccine is to grow selected SARS-CoV-2 in a suitable cell line to get more viruses in higher titre. The source of SARS-CoV-2 is obtained from selected patient samples, which is suitable as the vaccine candidate.

This work needs to be performed in a Level 3 Biosafety (BSL-3) laboratory, which is a higher containment laboratory. Only trained personnel are allowed to work in a BSL-3 laboratory. The laboratory is readily available at IMR, Setia Alam.

Q: Are there other pharmaceutical companies developing vaccines in the country, or is such research restricted to the Health Ministry only?

A: Covid-19 vaccine research is not restricted to the ministry. There are universities and other pharmaceutical companies which are also developing their own vaccines.

Pharmaniaga (Bhd) is doing the fill-and-finish process of producing the vaccine. There are also vaccine R&D arms in universities. However, there is not much information on them.

Q: What can you share about other companies or institutions in Malaysia that are currently part of the race, and the type of vaccines that they are developing? Do they involve cooperating with IMR/NIH?

A: IMR/NIH is not in charge of monitoring Covid-19 vaccine research conducted by other companies or entities in Malaysia.

Universiti Malaya's Tropical Infectious Diseases Research, Education Centre, Universiti Sains Malaysia and the International Medical University are among the higher-learning institutions working to develop vaccines too, which IMR has been roped in to collaborate.

However, I'm unable to share the details, as we have signed a non-disclosure agreement.



The Institute for Medical Research laboratory in Setia Alam is equipped with Level 3 Biosafety facilities. -NSTP/ASYRAF HAMZAH

Currently the Roadmap for Vaccine Development in the country is being drafted under the purview of Science, Technology and Innovation Ministry (Mosti). This roadmap is a collaborative effort between Mosti and the Health, Higher Education and Defence Ministries.

Q: What is IMR's chance of coming up with a working vaccine within the stipulated timelines? Are you optimistic or prepared for it to go either way, based on the overall vaccine R&D success rates and the timelines?

A: This is a relatively new venture for IMR. I'm optimistic with the stipulated timelines for these two projects.

The inactivated virus vaccine is progressing really well.

Of course, we cannot compete with (other) institutions that have been conducting vaccine research for a long time. However, we are taking small confident steps towards achieving our goals.



IMR researchers involved in developing the Covid-19 mRNA and inactivated virus vaccines have background experience in microbiology, immunology and vaccinology. -NSTP/ASYRAF HAMZAH

Q: Why does Malaysia need its own vaccines now, when the market is filling up with products from other countries? Would our resources be better spent towards researching the virus in the hopes of finding a cure or proper treatment? What are the benefits of going through such a tedious process, knowing that chances of any discovery (of a viable vaccine) could be slim?

A: Before we faced this pandemic, we felt that way too — buying is cheaper and easier. However, when it happened, we realised that we cannot depend entirely on others and that we need to develop our own capacity in producing vaccines.

We don't want to have total dependency on others, we need to stand on our own. This is our mentality now when it comes to vaccines development. We'll never know what pandemic may strike in the future. At least, by making headway with these two platforms, we will gain some experience in vaccine R&D to prepare us for other pandemics.

Malaysia also needs to have its own vaccine manufacturing facilities, so we can produce our vaccines quickly and protect our population. We should be able to be self-sufficient as we face future pandemics, in terms of having our own vaccines.



The vaccine technologies that IMR researchers are developing is not only for Covid-19. The technology can be used for other viruses or bacteria, and even immunotherapy, which is important in the country. IMR is strengthening its human resources to realise the Roadmap for Vaccine Development in Malaysia.

Q: How do we make sure that the (vaccine) candidates get regulatory approvals?

A: The IMR researchers are working closely with the National Pharmaceutical Regulatory Agency (NPRA) to ensure that all the requirements are met. This measure is to make sure that the candidate vaccines will surpass all stages in order to be used in the country.

The regulatory bodies will be involved from the beginning of the project, so we know what needs to be done and comply with it. We want our vaccines to be safe and efficacious for human use. Therefore, adhering to the requirements by the regulatory body is of utmost importance.
https://www.nst.com.my/news/nation/2...r-own-vaccines
Reply With Quote
     
     
  #8  
Old Posted Jul 15, 2021, 5:21 AM
nazrey's Avatar
nazrey nazrey is offline
Moderator
 
Join Date: Mar 2004
Posts: 1,869
Institute for Medical Research (IMR) | National Institutes of Health (NIH)
Seksyen U13 Setia Alam - Shah Alam, Selangor






http://gdparchitects.com/2015/?project=the-hub-ss2-2
Reply With Quote
     
     
  #9  
Old Posted Jul 16, 2021, 12:31 PM
nazrey's Avatar
nazrey nazrey is offline
Moderator
 
Join Date: Mar 2004
Posts: 1,869
First Malaysian made Covid-19 rapid antigen testing kit available from July 19
Bernama July 16, 2021 18:25 pm +08

Quote:
KUALA LUMPUR (July 16): The first Malaysian made Covid-19 rapid antigen self-testing kit — Salixium Covid-19 Rapid Antigen Test — will be available for public purchase this coming Monday, said MeDKAD Sdn Bhd.

MeDKAD project manager Syahriah Razak said the Salixium kit can detect the presence of SARS-CoV-2 antigen in human saliva and anterior nasal swab specimens.

The rapid test takes 10 to 15 minutes to perform and the result is judged by visible bands which confirm the presence of the antigen.

Founded in 2016 and based in Shah Alam, Selangor, MeDKAD is a health technology company that empower companies to better manage their medical benefits.
https://www.theedgemarkets.com/artic...ilable-july-19
Reply With Quote
     
     
  #10  
Old Posted Jul 16, 2021, 12:38 PM
nazrey's Avatar
nazrey nazrey is offline
Moderator
 
Join Date: Mar 2004
Posts: 1,869
Malaysia administered highest daily number of Covid-19 vaccine doses at 460,158 on July 15
Syafiqah Salim July 16, 2021 10:51 am +08


Quote:
KUALA LUMPUR (July 16): Malaysia administered yesterday (July 15) its highest daily number of Covid-19 vaccine doses at 460,158 compared 434,828 a day earlier (July 14), according to the latest updates on Twitter today by the country’s Special Committee for Ensuring Access to Covid-19 Vaccine Supply (JKJAV), citing data from the Covid-19 Immunisation Task Force (CITF).

The CITF said that yesterday's 460,158 vaccine shots comprised 304,807 first doses and 155,351 second doses for recipients.
https://www.theedgemarkets.com/artic...460158-june-15
Reply With Quote
     
     
  #11  
Old Posted Jul 16, 2021, 12:43 PM
nazrey's Avatar
nazrey nazrey is offline
Moderator
 
Join Date: Mar 2004
Posts: 1,869
Malaysia to stop using Sinovac vaccine after supply ends — Minister
Rozanna Latiff July 15, 2021 20:14 pm +08
Quote:
KUALA LUMPUR (July 15): Malaysia's Health Ministry on Thursday said the country will stop administering the Covid-19 vaccine produced by China's Sinovac once its supplies end, as it has a sufficient number of other vaccines for its programme.

Malaysia's inoculation drive will be largely anchored by the Pfizer-BioNTech mRNA vaccine moving forward, Health Minister Adham Baba told a news conference with other top Ministry officials.

The Southeast Asian country has secured about 45 million doses of the Pfizer-BioNTech vaccine, enough to cover 70% of the population, compared with 16 million doses of Sinovac's shot, the officials said.

"About half of the 16 million have already been distributed, so the rest will be used to cover second doses," Adham said.

"For those who have yet to be vaccinated, they will receive the Pfizer vaccine."
https://www.theedgemarkets.com/artic...ealth-minister
Reply With Quote
     
     
  #12  
Old Posted Jul 16, 2021, 1:15 PM
nazrey's Avatar
nazrey nazrey is offline
Moderator
 
Join Date: Mar 2004
Posts: 1,869
GLOBAL INNOVATION INDEX 2020
G7 / Some Asian Nations

Graduates in science & engineering, % pop
4 Malaysia 40.8%
6 Germany 35.6%
8 Singapore 34.9%
12 India 31.7%
18 South Korea 29.3%
24 Thailand 27.9%
31 UK 26.3%
33 France 25.6%
49 Italy 23.3%
60 Canada 21.3%
79 USA 17.9%

Researchers, FTE/million pop
3 South Korea 7,980.4
6 Singapore 6,802.5
13 Japan 5,331.
15 Germany 5,211.9
19 France 4,715.3
20 UK 4,603.3
23 USA 4,412.4
24 Canada 4,263.8
35 Malaysia 2,396.5
38 Italy 2,306.8
47 Thailand 1,350.3
48 China 1,307.1

Source: https://www.wipo.int/edocs/pubdocs/e...b_gii_2020.pdf
Reply With Quote
     
     
  #13  
Old Posted Jul 17, 2021, 10:25 PM
nazrey's Avatar
nazrey nazrey is offline
Moderator
 
Join Date: Mar 2004
Posts: 1,869
Malaysia now has one of the world's fastest vaccination rates
Bernama July 15, 2021 22:18 pm +08

Quote:
KUALA LUMPUR (July 15): Malaysia now boasts one of the fastest vaccination rates in the world, doling out more than 400,000 doses a day, out-performed in the past week only by Canada among countries of a similar size or greater, and double the pace of Australia.

Based on an analysis piece published in The Sydney Morning Herald, the online portal said amid the death and despondency in this South-East Asian nation of 32 million, there is, however, one silver lining — the vaccination rates that ramp up.
https://www.theedgemarkets.com/artic...cination-rates
Reply With Quote
     
     
  #14  
Old Posted Aug 5, 2021, 1:03 AM
nazrey's Avatar
nazrey nazrey is offline
Moderator
 
Join Date: Mar 2004
Posts: 1,869
Reply With Quote
     
     
  #15  
Old Posted Aug 15, 2021, 3:20 AM
nazrey's Avatar
nazrey nazrey is offline
Moderator
 
Join Date: Mar 2004
Posts: 1,869
Dr Adham: 31.9% of Malaysian population fully vaccinated as of Aug 14
Bernama August 15, 2021 09:50 am +08
Quote:
KUALA LUMPUR (Aug 15): A total of 31.9% or 10,425,300 of the country's population had completed two doses of Covid-19 vaccination as of yesterday (Aug 14), said Health Minister Datuk Seri Dr Adham Baba.

Dr Adham, through an infographic shared on his official Twitter, said, a total of 16,868,615 people or 51.7% had received the first dose, bringing the cumulative number of doses administered under the National Covid-19 Immunisation Programme (PICK) to 27,293,915 doses as of yesterday.

Follow our Covid-19 vaccination tracker to see where we are in the race to herd immunity.

In terms of percentage, 72.1% of the country's adult population had received the first dose while 44.5% had completed both doses.

Meanwhile, on daily vaccination rate, he said a total of 442,150 doses were administered yesterday with 161,049 being the first dose while 281,101 the second dose.

PICK was launched on Feb 24 to contain the Covid-19 pandemic, which hit the country last year.
https://www.theedgemarkets.com/artic...lly-vaccinated
Reply With Quote
     
     
  #16  
Old Posted Aug 15, 2021, 3:25 AM
nazrey's Avatar
nazrey nazrey is offline
Moderator
 
Join Date: Mar 2004
Posts: 1,869
Malaysia selected by WHO to test effectiveness of new drugs to cure Covid-19
Bernama August 14, 2021 01:06 am +08
Quote:
PUTRAJAYA (Aug 13): Malaysia will conduct a study on three types of drugs to treat Covid-19 patients following large-scale international trials announced by the World Health Organisation (WHO) yesterday.

Health director-general Tan Sri Dr Noor Hisham Abdullah said Malaysia was selected to carry out the research and hoped to help WHO to obtain data on the effectiveness of three new drugs namely artesunate, imatinib and infliximab.

“We hope we can help WHO to obtain the data, and we have enough patients to conduct the study,” he told a press conference on the development of Covid-19 today.

Also present were Health Minister Datuk Seri Dr Adham Baba, the Ministry’s secretary-general Datuk Mohd Shafiq Abdullah, deputy Health director-general Datuk Dr Chong Chee Kheong, Selangor Health Department director Datuk Dr Sha’ari Ngadiman.

Dr Noor Hisham said artesunate is used for the treatment of severe malaria; imatinib, a drug for certain cancers (blood cancer and leukaemia); and infliximab, a treatment for immune system disorders such as Crohn’s Disease and rheumatoid arthritis.

"These three drugs have anti-viral effects. We want to study and see the effectiveness of these drugs to treat Covid-19 patients,” he added.

Dr Noor Hisham said Malaysia was previously selected by WHO for a solidarity test to research four types of medicine namely Remdesivir, Hydroxychloroquine, Lopinavir and Interferon.

However, he said the research trial results were obtained in October last year, and the initial results showed that they had little or no effect on hospitalised patients with Covid-19.

“For example, during the second wave, we used a lot of Hydroxychloroquine and Lopinavir, but the study proved that these drugs are not effective, and we have stopped using them,” he said.

Dr Noor Hisham said the test study on the use of three new drugs involved thousands of volunteer patients in 600 hospitals in 52 countries, which would further reassure and strengthen whether the use of the drugs was effective or otherwise.

Yesterday, WHO announced international trials on three new drugs to determine whether they can be used to treat Covid-19 patients in hospitals.

WHO said the drugs were selected by an independent panel of experts to see their potential in reducing the risks of death of the hospitalised Covid-19 patients.
https://www.theedgemarkets.com/artic...s-cure-covid19
Reply With Quote
     
     
  #17  
Old Posted Aug 15, 2021, 3:27 AM
nazrey's Avatar
nazrey nazrey is offline
Moderator
 
Join Date: Mar 2004
Posts: 1,869
With more people fully vaccinated, hospital admission of category 3-5 covid-19 patients decreased — Health DG
Bernama August 13, 2021 22:56 pm +08
Quote:
PUTRAJAYA (Aug 13): The number of category three to five Covid-19 patients requiring hospitalisation in five States has reduced, thanks to the increasing number of fully vaccinated people among the adult population in those States.

Health director-general Tan Sri Dr Noor Hisham Abdullah said with more people fully vaccinated, the use of intensive care unit (ICU) beds for all three categories in Labuan, Sarawak, Negeri Sembilan, Kuala Lumpur and Putrajaya has been reduced.

“We find that when the full vaccination rate among the adult population, aged 18 and above in Labuan reached 63.4%, Sarawak (55.7%), Negeri Sembilan (40.1%), Kuala Lumpur (78.3%) and Putrajaya (69.3%), there was a reduction in admission of category three to five patients to hospitals and ICUs.

“Other States have not shown a declining trend as the percentage of completed doses is still low,” he told a media conference about the developments of Covid-19 here today.

Dr Noor Hisham said the reduction could also be seen at Sungai Buloh Hospital after the government implemented the capacity surge operation at the Klang Valley to speed up vaccinations among the adult population.
https://www.theedgemarkets.com/artic...-decreased-—
Reply With Quote
     
     
  #18  
Old Posted Aug 15, 2021, 3:35 AM
nazrey's Avatar
nazrey nazrey is offline
Moderator
 
Join Date: Mar 2004
Posts: 1,869
Covid-19: Malaysia's daily vaccination doses rise to 525,342 on Aug 12; over a quarter of nation's population fully inoculated
Cheryl Poo August 13, 2021 12:00 pm +08


Quote:
KUALA LUMPUR (Aug 13): Malaysia's daily vaccination rate increased to 525,342 doses yesterday (Aug 12), from 497,352 reported for the previous day, according to the latest data from the Covid-19 Immunisation Task Force (CITF).

As a result, the seven-day moving average of daily doses administered rose to 444,120 from 442,596.

A total of 3.72 million adults or 44% of the total population of the Klang Valley had received their two-dose vaccination as of yesterday.

A total of 6.35 million adults in Selangor, Kuala Lumpur and Putrajaya had received at least their first dose, translating into 75.36% of the total population of the Klang Valley.
https://www.theedgemarkets.com/artic...ons-population
Reply With Quote
     
     
  #19  
Old Posted Aug 18, 2021, 11:55 PM
nazrey's Avatar
nazrey nazrey is offline
Moderator
 
Join Date: Mar 2004
Posts: 1,869
52.8% of country's population have received at least one dose of vaccine as of Aug 16, with 33.9% fully vaccinated — JKJAV
Esther Lee August 17, 2021 11:01 am +08
Quote:
-A+A

KUALA LUMPUR (Aug 17): The country’s daily number of Covid-19 vaccine doses administered inched up to 501,776 yesterday (Aug 16), from 415,875 the previous day, bringing the total number of vaccine shots given to recipients to 28.31 million so far since the vaccination programme started early this year.

Based on the latest updates on Twitter today by the country’s Special Committee for Ensuring Access to Covid-19 Vaccine Supply (JKJAV), which cited data from the Covid-19 Immunisation Task Force (CITF), Malaysia had as of yesterday administered the first dose of the vaccine to 52.8% of the country’s population and the second dose to 33.9% of the population.
https://www.theedgemarkets.com/artic...ding-339-fully
Reply With Quote
     
     
  #20  
Old Posted Aug 23, 2021, 11:05 AM
nazrey's Avatar
nazrey nazrey is offline
Moderator
 
Join Date: Mar 2004
Posts: 1,869
More than 55% of adults in Malaysia fully vaccinated as at Aug 22; total administered dose at 31.28 mil
Esther Lee August 23, 2021 11:36 am +08



Quote:
KUALA LUMPUR (Aug 23): More than 55% of the adult population in Malaysia have been fully vaccinated as of yesterday (Aug 22), amounting to 13.02 million individuals, according to the latest updates on Twitter today by the country’s Special Committee for Ensuring Access to Covid-19 Vaccine Supply (JKJAV).

Meanwhile, the data, which was cited from the Covid-19 Immunisation Task Force (CITF), showed that Malaysia had as of yesterday administered at least one dose of vaccine to 18.26 million people, amounting to 55.9% of total population. On Aug 21, the number stood at 18.12 million, or 55.5% of total population.

It is worth noting that the 18.26 million, or 55.9% of total population, receiving at least one dose of vaccine include those who had been fully vaccinated.
https://www.theedgemarkets.com/artic...-dose-3128-mil
Reply With Quote
     
     
This discussion thread continues

Use the page links to the lower-right to go to the next page for additional posts
 
 
Reply

Go Back   SkyscraperPage Forum > Regional Sections > Asia-Pacific > Malaysia
Forum Jump


Thread Tools
Display Modes

Forum Jump


All times are GMT. The time now is 8:34 PM.

     

Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2021, vBulletin Solutions, Inc.